Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Net Income
(36,308)
(28,019)
(93,295)
(34,898)
Operating Activities, Cash Flows Provided By or Used In
Depreciation
6,287
6,214
7,608
7,788
Changes In Accounts Receivables
(25,428)
1,325
7,733
2,301
Changes In Assets and Liabilities
(8,430)
(84)
(6,667)
9,490
Changes In Inventories
(1,250)
(1,627)
(1,492)
2,972
Changes In Other Operating Activities
45,911
10,880
67,103
10,389
Total Cash Flow From Operating Activities
(19,218)
(11,311)
(19,010)
(1,958)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures
(3,411)
(2,769)
--
(2,502)
Investments
--
--
--
--
Other Cash flows from Investing Activities
500
4,200
600
11,882
Total Cash Flows From Investing Activities
(2,911)
1,431
600
9,380
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid
--
--
--
--
Sale/Purchase of Stock
29
(68)
41
58
Net Borrowings
--
--
0
0
Other Cash Flows from Financing Activities
0
0
0
0
Total Cash Flows From Financing Activities
29
(68)
41
58
Effect Of Exchange Rate Changes
34
10
115
(7)
Change In Cash and Cash Equivalents
(22,100)
(9,948)
(18,369)
7,480